ADVANCE-HTA is a research project funded by the European Commission's Research Framework Programme (FP7). It comprises several complementary streams of research that aim to advance and strengthen the methodological tools and practices relating to the application and implementation of Health Technology Assessment (HTA).

AETIONOMY is a consortium brought together under the European IMI to tackle the problem of the classification of neuro-degenerative diseases. Revising the taxonomy (classification) will take many years to complete and to be accepted by the biomedical community.

The EU-funded AD Detect-Prevent project, which is led by the Danish company Brain+, kicked-off in late 2018 and will continue over the next two years with the aim of developing a digital tool to improve early detection of Alzheimer’s disease.

ASCTN-Training is a four-year project, funded by the European Union Horizon 2020 Programme (H2020-MSCA-ITN-2018) under the Marie Skłodowska-Curie Initial Training Network and Grant Agreement No. 813851.

Coordinated by EBC, EBRA enhances coordination and collaboration among members that share the common goal of understanding the brain and its disorders by synergising brain related projects and initiatives at both European and global level ...

MARATONE is a Marie Curie Initial Training Network project that directly addresses the need for high-level training and career pathways in mental health to increase the inter-sectorial and trans-national employability of young scientists in the academic, public and private sectors to meet the enormous challenge of the 2009 EU Parliament Resolution on Mental Health.

The EU-funded MULTI-ACT project aims to increase the impact of health research on people with brain diseases. It will create and implement a new model allowing for the effective cooperation of all relevant stakeholders.

Science and technology advances rapidly. The NERRI project works to establish productive dialogue between potential users, potential “designers” (researchers, engineers, developers) and potential legislators of Neuro-Enhancement technologies, before products start to hit the marketplace.

The Oxford Participation and Activities Questionnaire Initiative aims to develop a short patient reported outcome measure designed specifically to assess participation, activities and level of independence.

Paradise was an EU funded project under the Seventh Framework Programme (FP7). The objective of PARADISE was to develop and test an innovative approach to collect clinical data on the psychosocial difficulties that people experience when they suffer from brain disorders.